Formulations of bendamustine | Patent Number 10010533

US 10010533 B2
Application Number15432335
Publication NumberUS 20180000789 A1
Pendency1 year, 4 months, 19 days
Filled DateFeb 14, 2017
Priority DateJan 28, 2010
Publication DateJan 4, 2018
Expiration DateJan 27, 2030
Inventor/ApplicantsNagesh R. Palepu
Philip Christopher Buxton
ExaminesARNOLD, ERNST V
Art Unit1613
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.